MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2020

    KMT2B-related disorders: Expansion of the phenotypic spectrum and long-term efficacy of deep brain stimulation

    L. Cif, D. Demailly, J. Lin, K. Barwick, D. Steel, M. Sa, N. Dorison, D. Doummar, L. Lion François, P. Coubes, K. Gorman, M. Kurian (Pierre-Bénite, France)

    Objective: Clarifying clinical phenotype, molecular genetic features and evolution with deep brain stimulation (DBS) of KMT2B related disease. Background: Heterozygous mutations in KMT2B are associated…
  • MDS Virtual Congress 2020

    Concordance of different evaluation approaches of non-motor symptoms in patients with cervical dystonia

    V. Han, K. Kulcsarova, J. Ventosa, Z. Gdovinova, M. Skorvanek (Kosice, Slovakia)

    Objective: The aim of our study was to assess the concordance of different evaluation approaches of non-motor symptoms (NMS) in patients with cervical dystonia (CD).…
  • MDS Virtual Congress 2020

    De-novo ß-actin mutation as a cause of seemingly sporadic dystonia-deafness syndrome responsive to deep-brain stimulation

    N. Schell, J.K Krauss, A. Saryyeva, C. Klein, N. Brüggemann (Luebeck, Germany)

    Objective: To elucidate the cause of dystonia and deafness in a 37-year-old woman and to evaluate the response to deep brain stimulation (DBS). Background: Dystonia-deafness…
  • MDS Virtual Congress 2020

    Regional, Not Global, Functional Connectivity Contributes to Isolated Focal Dystonia

    S. Norris, A. Morris, M. Campbell, M. Karimi, A. Babatunde, R. Paniello, A. Snyder, J. Mink, J. Perlmutter (St. Louis, MO, USA)

    Objective: To test the hypothesis that there is shared regional or global functional connectivity dysfunction in a large cohort with isolated focal dystonia affecting different…
  • MDS Virtual Congress 2020

    Management of Dystonia in Europe from Patients’ Experience

    M. Relja, V. Miletic (Zagreb, Croatia)

    Objective: To investigate management of dystonia in Europe from patients' experience obtained from on-line survey. Background: We have reported a lack of specific training in…
  • MDS Virtual Congress 2020

    Initial Results from the Zambian Epidemiology of Parkinson’s disease and Healthcare Registry (ZEPHyR)

    T. Lee, O. Siddiqi, M. Atadzhanov, D. Saylor, J. Fleisher (Aurora, CO, USA)

    Objective: To describe the launch and preliminary findings of ZEPHyR, the first Parkinson’s Disease (PD) registry in Zambia. Background: PD is the second most common…
  • MDS Virtual Congress 2020

    Estimation of latent class mixed models towards discovery of subgroup trajectories of MDS-UPDRS part II, part III, and ambulatory capacity in Parkinson’s disease

    C. Venuto, R. Zielinski, G. Smith, M. Javidnia, K. Kieburtz (Rochester, NY, USA)

    Objective: To use latent mixed modeling (LMM) for the identification of subgroups of people living with Parkinson’s disease (PD) who have statistically distinct trajectories of…
  • MDS Virtual Congress 2020

    Atypical alternating hemiplegia of childhood in Korea: A case report

    C. Shin, H. Kim, B. Jeon (Daejeon, Republic of Korea)

    Objective: To report an atypical case of alternating hemiplegia of childhood (AHC), which has not yet been reported in Korea. Background: The ATP1A3 gene pathologic…
  • MDS Virtual Congress 2020

    Epidemiology of Huntington’s Disease (HD) in the US Medicaid Population

    A. Exuzides, S. Reddy, E. Chang, C. Paydar, G. Yohrling (South San Francisco, CA, USA)

    Objective: To estimate the current prevalence of Huntington’s disease (HD) among Medicaid beneficiaries in the United States (US). Background: HD is a genetic, progressive, neurodegenerative…
  • MDS Virtual Congress 2020

    Development of a time-to-event endpoint for use in premanifest Huntington’s disease (HD) clinical trials

    S. Rossomanno, H. Guthrie, E.J Wild, S.A Schobel, L. Boak, D. Trundell (Basel, Switzerland)

    Objective: To develop and evaluate a time-to-event endpoint to measure disease progression in individuals with premanifest HD. Background: HD is typically diagnosed between the ages…
  • « Previous Page
  • 1
  • …
  • 102
  • 103
  • 104
  • 105
  • 106
  • …
  • 149
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley